Technology | Implantable Cardiac Monitor (ICM) | February 14, 2017

Biotronik Launches ProMRI Configurator Online Tool

The online tool provides physicians with a quick and easy way to proactively select device systems that would allow heart patients access to MRI scans

Biotronik, ProMRI Configurator tool, MR-conditional cardiac devices, ProMRI SystemCheck

February 14, 2017 — Biotronik has developed an online tool that streamlines the workflow for physicians selecting the right magnetic resonance (MR)-conditional heart monitor or pacing or implantable cardioverter defibrillator (ICD) system for their patients.

The ProMRI Configurator is an intuitive, user-friendly tool that allows physicians to select the desired MRI conditions, subsequently generating a selection of all suitable MR-conditional cardiac devices and leads approved and available in their country. In this way, physicians can ensure that patients receive the most appropriate MR-conditional cardiac system for access to MRI in case of a new implantation or a replacement.

Biotronik manufactures a broad range of MR-conditional devices, along with a wide assortment of leads, offering a variety of options and combinations for different MR conditions. The ProMRI Configurator brings ease and convenience to the physician trying to find the most suitable setup for the individual patients’ MRI needs.

The online tool marks the second offering of the ProMRI Check online platform. The first tool — the ProMRI SystemCheck — allows physicians and patients to retrospectively check whether an implanted cardiac system is MR-conditional. The ProMRI Configurator enhances the platform with its focus on the proactive selection of an MR-conditional system.

Last year, Biotronik won the Cardiostim Innovation Award in the category “Best Practice Improvement” for its MRI AutoDetect feature in implantable cardioverter defibrillators, cardiac resynchronization devices and pacemakers. MRI AutoDetect recognizes an MRI environment and automatically switches to and from MRI mode without the cardiologist’s intervention. This not only eases the workflow for patients, physicians and radiologists, but also adds to patients’ safety.

For more information: www.promricheck.com


Related Content

News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
News | EP Lab

Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance ...

Home November 05, 2022
Home
News | EP Lab

October 14, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of ...

Home October 14, 2022
Home
Feature | EP Lab | By Vijay Kundekar

Arrhythmias can be described as irregular heart rhythms that are brought on by numerous factors, including heart damage ...

Home August 23, 2022
Home
News | EP Lab

May 24, 2022 — Attune Medical, a pioneering medical device company with a technology platform based on temperature ...

Home May 24, 2022
Home
Subscribe Now